FB704A

Fountain Biopharma Inc. · Phase 2 active Small molecule

At a glance

Generic name	FB704A
Sponsor	Fountain Biopharma Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma (PHASE2)
Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704A (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FB704A CI brief — competitive landscape report
FB704A updates RSS · CI watch RSS
Fountain Biopharma Inc. portfolio CI